BiondVax Pharmaceuticals Ltd.

(NASDAQ:BVXV) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


BiondVax Pharmaceuticals Ltd.

Profile

BiondVax is a publicly traded, innovative biopharmaceutical company developing a Universal Flu Vaccine, providing multi-season and multi-strain protection against all human influenza virus strains, both seasonal and pandemic.

Contact Information

Website: www.biondvax.com
Main Phone: +972 89302529
Address: Hadassah Ein Kerem Campus
Address 2: Jerusalem BioPark, 2nd floor
City / Town: Jerusalem
Country: IL
Postal Code: 74036

Issuer Information

Exchange: NSC
CEO: Ron Babecoff
Employees: 25

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A